These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18291718)

  • 1. Effectiveness of ropinirole for RLS and depressive symptoms in an 11-year-old girl.
    Cortese S; Konofal E; Lecendreux M
    Sleep Med; 2009 Feb; 10(2):259-61. PubMed ID: 18291718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
    Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L; Ritchie SY; Kirsch JM
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
    Allen RP; Ritchie SY
    Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
    Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
    Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
    Montplaisir J; Karrasch J; Haan J; Volc D
    Mov Disord; 2006 Oct; 21(10):1627-35. PubMed ID: 16874755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ropinirole in restless leg syndrome.
    Ahmed I
    Mo Med; 2002; 99(9):500-1. PubMed ID: 12462942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep).
    Allen RP; Kosinski M; Hill-Zabala CE; Calloway MO
    Sleep Med; 2009 May; 10(5):531-9. PubMed ID: 18805054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
    Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
    Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
    Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient- and physician-rated measures demonstrate the effectiveness of ropinirole in the treatment of restless legs syndrome.
    Kushida CA; Geyer J; Tolson JM; Asgharian A
    Clin Neuropharmacol; 2008; 31(5):281-6. PubMed ID: 18836346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome.
    Garcia-Borreguero D; Grunstein R; Sridhar G; Dreykluft T; Montagna P; Dom R; Lainey E; Moorat A; Roberts J
    Sleep Med; 2007 Nov; 8(7-8):742-52. PubMed ID: 17512789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Restless-legs syndrome].
    Karroum E; Konofal E; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of ropinirole in the treatment of chronic insomnia secondary to restless legs syndrome: polysomnography data].
    Estivill E; de la Fuente V
    Rev Neurol; 1999 Nov 1-15; 29(9):805-7. PubMed ID: 10696651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restless legs syndrome: clinical experience with long-term treatment.
    Clavadetscher SC; Gugger M; Bassetti CL
    Sleep Med; 2004 Sep; 5(5):495-500. PubMed ID: 15341896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients.
    Hornyak M; Hundemer HP; Quail D; Riemann D; Voderholzer U; Trenkwalder C
    Clin Neurophysiol; 2007 Jul; 118(7):1532-7. PubMed ID: 17531532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.